Patent · US Active

Rapamycin assay

USRE40596E1 · kind E1 · reissue

0Cited by

16References

4Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Richard Sedrani · Basel, CH
Valérie Quesniaux Ryffel · Saint-Denis-en-Val, FR

Key dates

Filing date	Feb 6, 2007
Grant date	Dec 2, 2008
Priority date	—
Expiry date	Feb 6, 2027

Classification

Technology area (CPC —)General

Abstract

Monoclonal antibodies to rapamycin and to 40-O-alkylated derivatives of rapamycin are provided, together with novel haptens, immunogenic conjugates, and processes for making them and assay kits for using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.